Exocrine Pancreatic Insufficiency
📧 Sign up to get email alerts when something new happens for Exocrine Pancreatic Insufficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis [Phase 4]
Phase 4 clinical trial evaluating a Malabsorption Blood Test (MBT) to assess exocrine pancreatic function and related quality of life in chr…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 1 Study to Assess Safety and Efficacy of ANG003 [Phase 1]
Phase 1 trial update for ANG003 assessing safety and efficacy in Exocrine Pancreatic Insufficiency; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: Phase 1 Study to Assess Safety and Efficacy of ANG003 [Phase 1]
Phase 1 study evaluating ANG003 for safety and efficacy in exocrine pancreatic insufficiency has completed with results posted.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation [NA]
Clinical trial update focusing on managing steatorrhea due to exocrine pancreatic insufficiency in children and young adults with Alagille s…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
A clinical trial is recruiting to assess pancreatic dysfunction in patients with Type 2 diabetes, investigating pancreatogenic diabetes mell…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Phase 2 Study to Assess the Safety and Efficacy of ANG003 [Phase 2]
Phase 2 clinical trial to evaluate the safety and efficacy of ANG003 for exocrine pancreatic insufficiency and cystic fibrosis. The study st…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: THE MALABSORPTION BLOOD TEST TRIAL WILL HELP DETERMINE THE BENEFITS OF PANCREATIC ENZYME REPLACEMENT THERAPY IN PATIENTS WITH MILD TO MODERATE EXOCRINE PANCREATIC INSUFFICIENCY. [Phase 4]
A Phase 4 clinical trial update evaluating a malabsorption blood test. The study aims to determine the potential benefits of pancreatic enzy…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects [Phase 4]
A Phase 4 clinical trial evaluating injectable secretin (Chirostim) on pancreatic fluid composition in healthy subjects is sponsored by Mayo…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure [NA]
An update on an ongoing clinical trial evaluating RELiZORB for treating feeding intolerance in critically ill adults with multi-organ failur…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation
This clinical trial examines whether pancreatic exocrine secretion contributes to weight gain after pancreas transplantation. The study is c…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency [Phase 4]
A Phase 4 clinical trial sponsored by Ohio State University is recruiting to evaluate pancreatic enzyme replacement therapy for exocrine pan…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Exocrine Pancreatic Insufficiency and Functional Dyspepsia
This clinical trial update indicates that the study on Exocrine pancreatic insufficiency and dyspepsia is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Fatty Liver and Pancreatic Steatosis
The clinical trial is investigating Exocrine Pancreatic Insufficiency with fatty liver disease, including nonalcoholic fatty liver disease a…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients [Phase 3]
Phase 3 trial evaluating RELiZORB for managing exocrine pancreatic insufficiency in tube-fed pancreatitis patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: BÜHLMANN FPELA in the Diagnosis of Exocrine Pancreatic Insufficiency
Clinical trial update reporting completion of a study evaluating the BÜHLMANN FPELA diagnostic test for Exocrine Pancreatic Insufficiency.
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Oral CDX-7108 in Healthy Adults and EPI Subjects [Phase 1]
Phase 1 study of oral CDX-7108 in healthy adults and subjects with Exocrine Pancreatic Insufficiency has completed, sponsored by Société des…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis [Phase 2]
Phase 2 study of an enteric microgranule formulation of Adrulipase in cystic fibrosis patients with exocrine pancreatic insufficiency has co…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Phase 1 Study to Assess Safety and Efficacy of ANG003 [Phase 1]
A Phase 1 study evaluating ANG003 for Exocrine Pancreatic Insufficiency has completed, assessing safety and preliminary efficacy.
-
FDA approval · 2024-02-28FDA Approved: CREON — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for CREON (pancrelipase) filed by AbbVie Inc.
-
FDA approval · 2024-02-28FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)
FDA approved a supplemental application for PANCREAZE, a pancreatic enzyme replacement product, submitted by VIVUS LLC.
-
FDA approval · 2023-11-20FDA Approved: VIOKACE — Supplemental Application (Aimmune Therapeutics, Inc.)
FDA approved a supplemental application for VIOKACE (pancrelipase) to update and expand its labeling. The action supports additional indicat…
-
FDA approval · 2023-10-27FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
The FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, Inc., updating its labeling for exo…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI) [Phase 4]
Phase 4 trial of Creon (pancrelipase) in pancreatic cancer patients with exocrine pancreatic insufficiency has been terminated; results post…
-
FDA approval · 2022-09-28FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, Inc., expanding/adjusting its labeling …
-
FDA approval · 2022-09-28FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
FDA approved a supplemental application for PERTZYE (pancrelipase) from Digestive Care, Inc., approving changes to the product's labeling. P…